Metraipolis › archive › dc_674b87449bca

Protocol for establishing a chemoresistant orthotopic triple-negative breast cancer patient-derived xenograft model for preclinical drug testing — Europe PMC PMID:41774544

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41774544
DOI
10.1016/j.xpro.2026.104394
License (as archived)
solo-consultazione
Archived
2026-11-05T10:05:12.329Z
SHA-256 of the archived text
386d644604c0fe9dbfaeaca187ec93c70e6b3f2875a37214bf113a11b27c0fa8
Stable URL of this page
https://metraipolis.com/documento/dc_674b87449bca

How to cite

Protocol for establishing a chemoresistant orthotopic triple-negative breast cancer patient-derived xenograft model for preclinical drug testing — Europe PMC PMID:41774544 — Europe PMC (en), https://europepmc.org/article/MED/41774544 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_674b87449bca (Metraipolis archive dc_674b87449bca, sha256 386d644604c0fe9dbfaeaca187ec93c70e6b3f2875a37214bf113a11b27c0fa8)
BibTeX
@misc{dc674b87449bca,
  title = {Protocol for establishing a chemoresistant orthotopic triple-negative breast cancer patient-derived xenograft model for preclinical drug testing — Europe PMC PMID:41774544},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41774544},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_674b87449bca; sha256 386d644604c0fe9dbfaeaca187ec93c70e6b3f2875a37214bf113a11b27c0fa8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41774544. Agents can read the archived copy with the MCP tool read_document.